U.S. Insurance Stock News

Earlier this month, Centene Corporation announced expanded Ambetter health insurance plan offerings for 2026 in Arizona, Mississippi, and Georgia, emphasizing affordable plans, customizable coverage, and enhanced member benefits such as Ambetter Perks, My Health Pays rewards, and 24/7 telehealth services. This expansion highlights Centene's ongoing focus on consumer-friendly digital enrollment, value-added programs, and tailored employer solutions, which may play a role in membership growth...

Aptiv (APTV) delivered strong third-quarter earnings that surpassed expectations, sparking investor interest ahead of its upcoming analyst day. The company is also set to discuss a possible spin-off of its software division, which hints at a new strategic focus. See our latest analysis for Aptiv. Aptiv’s upbeat earnings and its fresh robotics partnership with Robust.AI have put the spotlight back on the company’s transformation story, helping spark considerable momentum in the stock. While...

Clarivate recently reported its fiscal Q3 2025 results, showing a modest revenue increase driven by higher transactional sales in the government and academic sectors, and raised its full-year revenue outlook amid favorable currency effects. An interesting insight is that while transactional book sales and currency movements provided a boost, recurring subscription revenue growth came in below expectations, signaling ongoing challenges to sustainable long-term growth. We'll explore how...

ManpowerGroup (MAN) shares have continued their steady slide in recent weeks, with the stock down 15% over the past month. Investors are watching for signs of recovery as the staffing leader faces ongoing challenges. See our latest analysis for ManpowerGroup. ManpowerGroup's challenges have only accelerated this year, with the stock’s 30-day share price return at -15% and its year-to-date decline nearing 50%. A one-year total shareholder return of -52% highlights how far sentiment and...

Crinetics Pharmaceuticals (CRNX) just released its third quarter financials, showing a wider net loss compared to last year. This update is important for investors keeping an eye on the company’s trajectory. See our latest analysis for Crinetics Pharmaceuticals. Despite the steeper losses just reported, Crinetics Pharmaceuticals has climbed sharply in recent months, with a 43% share price return over the last quarter. However, momentum has yet to fully recover from longer-term declines...

Tetra Tech reported record financial results for the fourth quarter and fiscal year 2025, including record net revenue, operating income, and earnings per share, alongside a 12% year-on-year increase in its quarterly dividend payable on December 12, 2025. The company highlighted strong growth in high-end water infrastructure and digital automation services, while also announcing major contract wins with U.S. defense agencies and international clients, contributing to an expanding project...

Nelnet recently reported third-quarter and nine-month earnings, with net income reaching US$106.68 million for the quarter and US$370.7 million year-to-date, and also declared a US$0.33 per share dividend to be paid in December 2025. The company’s results reflect a dramatic rise in profitability compared to the previous year, driven by substantial gains in both quarterly and year-to-date earnings per share. We'll examine how Nelnet's significant earnings jump and shareholder dividend...

In recent announcements, MarketAxess Holdings reported third quarter and nine-month financial results, affirmed its quarterly dividend of US$0.76 per share, completed a US$95.33 million share buyback, and revealed the imminent launch of standardized Opening and Closing Auctions for U.S. credit trading on its platform. Consulting with major institutional participants to develop its new auction protocol highlights MarketAxess’s ongoing focus on enhancing liquidity and price discovery in the...

Hubbell recently completed its acquisition of DMC Power, enhancing its utility connector portfolio with advanced solutions for high-growth substation markets. An important detail is that the company expects the DMC Power acquisition to add approximately $0.20 per share in adjusted earnings by 2026, strengthening Hubbell's position in grid and electrification investments. We'll explore how the completed DMC Power acquisition may influence Hubbell's investment narrative and outlook for utility...

Strategic Education (STRA) recently posted a third quarter earnings report showing higher revenue and greater profitability, mainly supported by steady growth from its Sophia Learning and Workforce Edge platforms. Management highlighted ongoing operational efficiencies and robust employer-affiliated enrollments as positive trends. See our latest analysis for Strategic Education. Alongside the solid earnings beat, Strategic Education has been active with its buyback program, repurchasing...

NextDecade (NEXT) is drawing renewed attention after Hanwha Aerospace boosted its position by acquiring nearly 592,000 shares. At the same time, the company advanced its Rio Grande LNG project with final investment decisions and $13.4 billion in project funding. See our latest analysis for NextDecade. NextDecade’s recent operational milestones and insider buying have helped steady investor sentiment, even as near-term share price performance remains volatile. Despite a sharp pullback with a...

Impinj (PI) shares have faced pressure over the past month, with the stock declining nearly 29%. Investors seem to be weighing the company’s fundamentals and considering whether current levels could present a potential long-term opportunity. See our latest analysis for Impinj. After a long stretch of gains, Impinj’s 1-year total shareholder return is now down 19.3% as momentum cooled sharply in recent weeks. While the latest 1-month share price return of -29.3% captures the recent slide, the...

Ulta Beauty (ULTA) shares caught investor attention as the company announced it will end its long-running shop-in-shop partnership with Target in August 2026 and opened its first standalone store in the Middle East. These business moves could shape Ulta's growth outlook going forward. See our latest analysis for Ulta Beauty. Ulta Beauty's share price has gained solid momentum this year, with a 23.3% share price return year-to-date and a strong 44.96% total shareholder return over the past...

Apogee Therapeutics (APGE) is in the spotlight after sharing positive interim data from its Phase 1 trial of APG333. The experimental antibody showed a longer half-life and favorable safety profile in healthy volunteers. See our latest analysis for Apogee Therapeutics. Momentum around Apogee Therapeutics has been building fast, with the 1-day share price return jumping 4% after upbeat Phase 1 trial results and a successful $345 million capital raise. That excitement has fueled a striking...

Agios Pharmaceuticals announced that new clinical and preclinical data on mitapivat, its oral pyruvate kinase activator, were featured in multiple presentations at the 67th American Society of Hematology (ASH) Annual Meeting held in Orlando from December 6-9, 2025. The presentations highlighted mitapivat's potential to significantly reduce transfusion needs in thalassemia and provided early evidence of protection against heart complications, an important concern for patients with hemolytic...

Molson Coors Beverage (TAP) stock dipped slightly this week, catching some attention from investors tracking longer-term trends. Shares have drifted nearly 19% lower since January, raising questions about the outlook and underlying factors shaping its trajectory. See our latest analysis for Molson Coors Beverage. Molson Coors Beverage’s share price has steadily lost ground over the last year, closing recently at $46.44, and momentum seems to be fading after a string of weaker total...

Organon & Co. recently reported third quarter 2025 earnings, showing sales of US$1.60 billion and net income of US$160 million, while also lowering its full-year revenue guidance to a range of US$6.20 billion to US$6.25 billion. The company's latest results reflected a significant drop in net income compared to the prior year, signaling that margin pressures and revised expectations are influencing its financial outlook. We'll explore how Organon's reduced full-year revenue outlook and...

BlackLine (BL) released its third quarter results, showing higher revenue from last year; however, net income and earnings per share moved lower. The company also issued fresh revenue guidance for the upcoming quarter and year. See our latest analysis for BlackLine. BlackLine’s latest earnings update and new revenue guidance came just as the share price was working to recover from a bumpy first half of the year. While the 1-month share price return of 9.7% suggests recent momentum is...

Advanced Micro Devices (AMD) grabbed attention at its recent Analyst Day by unveiling bold financial targets for the next several years. Management forecasted over 35% compound annual revenue growth, supported by strong demand for AI infrastructure chips. See our latest analysis for Advanced Micro Devices. Momentum has really built around AMD this year, with the stock notching a 104.6% year-to-date share price return and a one-year total shareholder return of nearly 83%. Fueling the gains,...

Broadstone Net Lease recently achieved substantial completion on the first of two MRO hangars at Dayton International Airport, supporting Sierra Nevada Corporation’s contract with the U.S. Air Force, while also advancing new build-to-suit projects for Hobby Lobby and Academy Sports. This wave of project launches and tenant-driven real estate development underscores BNL’s ability to secure high-value, mission-critical assets with stable, long-term rental streams. Let’s explore how the...

Arcutis Biotherapeutics recently announced the completion of patient enrollment in its INTEGUMENT-INFANT Phase 2 study of ZORYVE cream for atopic dermatitis in infants, alongside the publication of positive long-term safety and efficacy results for ZORYVE foam in seborrheic dermatitis. ZORYVE is now distinguished as a multi-award-winning, FDA-approved topical treatment with growing clinical endorsements and expanded indications across pediatric and adult dermatology populations. We'll...

Bruker Corporation recently reported a third quarter net loss of US$62.4 million and a 0.5% year-over-year decrease in sales, alongside a US$96.5 million goodwill impairment charge and a lowered financial outlook for fiscal 2025. Despite ongoing challenges, Bruker’s Board approved quarterly dividends for both common and preferred shareholders, highlighting a commitment to shareholder returns amid financial headwinds. We'll explore how the lowered financial outlook and substantial goodwill...

Earlier this month, Pathward Financial announced a partnership with Upstart Holdings to offer personal loans through Upstart's AI-driven lending marketplace, shortly after Upstart reported third-quarter revenue of US$277.11 million and net income of US$31.81 million. This flurry of activity included optimistic guidance for the full year and a major insider stock purchase by a top executive, signaling heightened confidence in Upstart's approach to financial technology and lending...

Teledyne Technologies (TDY) is drawing attention after unveiling its latest space-grade CMOS image sensors and revealing plans to open a new regional headquarters in Riyadh. These developments highlight the company’s efforts to expand into advanced imaging solutions and grow its regional presence. See our latest analysis for Teledyne Technologies. Following these product launches and Teledyne’s expansion in the Middle East, recent momentum has softened, with the share price retreating 10.85%...